Literature DB >> 16819203

Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells.

Yoshiyuki Hattori1, Makoto Sakaguchi, Yoshie Maitani.   

Abstract

Activated macrophages are the key effector cells in rheumatoid arthritis (RA) and secrete multiple mediators of inflammation including proinflammatory cytokines. We investigated delivery of a nuclear factor kappa B (NFkappaB) decoy by folate-linked lipid-based nanoparticles (NP-F) into murine macrophages. The expression of folate receptor (FR) in RAW264.7 cells activated by lipopolysaccaride was confirmed by strong expression of FR mRNA, and association of FITC-labeled folate-BSA conjugate. When transfected via NP-F, the NFkappaB decoy was strongly detected in the cytoplasm, and an inhibitory effect on the translocation of NFkappaB into the nucleus was observed at 0.03 microM of the decoy, suggesting that NP-F effectively delivered the NFkappaB decoy into the cytoplasm. This information is of value for the design of NFkappaB decoy carrier systems targeting FR in activated macrophages in gene therapy for autoimmune diseases such as RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819203     DOI: 10.1248/bpb.29.1516

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  18 in total

1.  Folate-immunoglobulin G as an anticancer therapeutic antibody.

Authors:  Hong Li; Yanhui Lu; Longzhu Piao; Jun Wu; Xiaojuan Yang; Sri Vidya Kondadasula; William E Carson; Robert J Lee
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

Review 2.  Advancing musculoskeletal research with nanoscience.

Authors:  Cameron P Brown
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

3.  Evaluation of osteoclastogenesis via NFκB decoy/mannosylated cationic liposome-mediated inhibition of pro-inflammatory cytokine production from primary cultured macrophages.

Authors:  Thuy Duong Dinh; Yuriko Higuchi; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2011-01-21       Impact factor: 4.200

4.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

Authors:  Thommey P Thomas; Sascha N Goonewardena; Istvan J Majoros; Alina Kotlyar; Zhengyi Cao; Pascale R Leroueil; James R Baker
Journal:  Arthritis Rheum       Date:  2011-09

5.  Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes.

Authors:  Jun Zhou; Yi-Ting Tsai; Hong Weng; David W Baker; Liping Tang
Journal:  Biomaterials       Date:  2011-09-03       Impact factor: 12.479

Review 6.  Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.

Authors:  Kasturee Chakraborty; Archana Tripathi; Sukumar Mishra; Argha Mario Mallick; Rituparna Sinha Roy
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

7.  Development of optical probes for in vivo imaging of polarized macrophages during foreign body reactions.

Authors:  David W Baker; Jun Zhou; Yi-Ting Tsai; Kaitlen M Patty; Hong Weng; Ewin N Tang; Ashwin Nair; Wen-Jing Hu; Liping Tang
Journal:  Acta Biomater       Date:  2014-04-13       Impact factor: 8.947

Review 8.  Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Authors:  Leila Farahmand; Behrad Darvishi; Keivan Majidzadeh-A
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Cell and tissue targeting of nucleic acids for cancer gene therapy.

Authors:  Verena Russ; Ernst Wagner
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

10.  Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections.

Authors:  Pavan Puligujja; Joellyn McMillan; Lindsey Kendrick; Tianyuzi Li; Shantanu Balkundi; Nathan Smith; Ram S Veerubhotla; Benson J Edagwa; Alexander V Kabanov; Tatiana Bronich; Howard E Gendelman; Xin-Ming Liu
Journal:  Nanomedicine       Date:  2013-05-13       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.